HUP9903171A3 - Use of duloxetine for the preparation of pharmaceutical compositions treating attention-deficit/hyperactivity disorder - Google Patents

Use of duloxetine for the preparation of pharmaceutical compositions treating attention-deficit/hyperactivity disorder

Info

Publication number
HUP9903171A3
HUP9903171A3 HU9903171A HUP9903171A HUP9903171A3 HU P9903171 A3 HUP9903171 A3 HU P9903171A3 HU 9903171 A HU9903171 A HU 9903171A HU P9903171 A HUP9903171 A HU P9903171A HU P9903171 A3 HUP9903171 A3 HU P9903171A3
Authority
HU
Hungary
Prior art keywords
duloxetine
deficit
preparation
pharmaceutical compositions
hyperactivity disorder
Prior art date
Application number
HU9903171A
Other languages
Hungarian (hu)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to HU9903171A priority Critical patent/HUP9903171A3/en
Priority claimed from PCT/US1996/012047 external-priority patent/WO1997003665A1/en
Publication of HUP9903171A2 publication Critical patent/HUP9903171A2/en
Publication of HUP9903171A3 publication Critical patent/HUP9903171A3/en

Links

HU9903171A 1996-07-18 1996-07-18 Use of duloxetine for the preparation of pharmaceutical compositions treating attention-deficit/hyperactivity disorder HUP9903171A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9903171A HUP9903171A3 (en) 1996-07-18 1996-07-18 Use of duloxetine for the preparation of pharmaceutical compositions treating attention-deficit/hyperactivity disorder

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1996/012047 WO1997003665A1 (en) 1995-07-24 1996-07-18 Treatment of attention-deficit/hyperactivity disorder
HU9903171A HUP9903171A3 (en) 1996-07-18 1996-07-18 Use of duloxetine for the preparation of pharmaceutical compositions treating attention-deficit/hyperactivity disorder

Publications (2)

Publication Number Publication Date
HUP9903171A2 HUP9903171A2 (en) 2000-02-28
HUP9903171A3 true HUP9903171A3 (en) 2001-04-28

Family

ID=89999376

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903171A HUP9903171A3 (en) 1996-07-18 1996-07-18 Use of duloxetine for the preparation of pharmaceutical compositions treating attention-deficit/hyperactivity disorder

Country Status (1)

Country Link
HU (1) HUP9903171A3 (en)

Also Published As

Publication number Publication date
HUP9903171A2 (en) 2000-02-28

Similar Documents

Publication Publication Date Title
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
ZA987552B (en) Pharmaceutical composition for combination of piperidino-alkanol-decongestant
IL138129A (en) Composition for therapy of estrogen-associated disorders
EP0703282A3 (en) Composition for surface treatment
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
IL115843A0 (en) Pharmaceutical composition containing cisapride-(l)-tartrate
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP9800396A3 (en) Pharmaceutical composition for treating dementia
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
HUP9903679A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
HUP9903688A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating autism
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
AU686084B3 (en) Pharmaceutical compositions for the treatment of depressive disorders
HUP9903171A3 (en) Use of duloxetine for the preparation of pharmaceutical compositions treating attention-deficit/hyperactivity disorder
KR100248098B1 (en) Pharmaceutical composition for the treatment of dementia
HU9902296D0 (en) Pharmaceutical composition for treating caltification
IL116680A0 (en) Pharmaceutical composition for the treatment of depression
IL119219A0 (en) Pharmaceutical compositions for treatment of the eyes
IL110895A0 (en) Pharmaceutical compositions for treatment of the eyes
GB9422910D0 (en) Composition for the treatment of hypothyroidism
IL119250A (en) Pharmaceutical composition for the treatment of syndrome x of reaven